BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1102 related articles for article (PubMed ID: 19782780)

  • 1. COMP-Ang1, a chimeric form of Angiopoietin 1, enhances BMP2-induced osteoblast differentiation and bone formation.
    Jeong BC; Kim HJ; Bae IH; Lee KN; Lee KY; Oh WM; Kim SH; Kang IC; Lee SE; Koh GY; Kim KK; Koh JT
    Bone; 2010 Feb; 46(2):479-86. PubMed ID: 19782780
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relaxin augments BMP-2-induced osteoblast differentiation and bone formation.
    Moon JS; Kim SH; Oh SH; Jeong YW; Kang JH; Park JC; Son HJ; Bae S; Park BI; Kim MS; Koh JT; Ko HM
    J Bone Miner Res; 2014 Jul; 29(7):1586-96. PubMed ID: 24643989
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bone morphogenetic protein-2 restores mineralization in glucocorticoid-inhibited MC3T3-E1 osteoblast cultures.
    Luppen CA; Smith E; Spevak L; Boskey AL; Frenkel B
    J Bone Miner Res; 2003 Jul; 18(7):1186-97. PubMed ID: 12854828
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Angiopoietin-1 Variant COMP-Ang1 Enhances BMP2-Induced Bone Regeneration with Recruiting Pericytes in Critical Sized Calvarial Defects.
    Choi H; Jeong BC; Hur SW; Kim JW; Lee KB; Koh JT
    PLoS One; 2015; 10(10):e0140502. PubMed ID: 26465321
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Osteoblast-specific Angiopoietin 1 overexpression increases bone mass.
    Suzuki T; Miyamoto T; Fujita N; Ninomiya K; Iwasaki R; Toyama Y; Suda T
    Biochem Biophys Res Commun; 2007 Nov; 362(4):1019-25. PubMed ID: 17825261
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low-level laser irradiation enhances BMP-induced osteoblast differentiation by stimulating the BMP/Smad signaling pathway.
    Hirata S; Kitamura C; Fukushima H; Nakamichi I; Abiko Y; Terashita M; Jimi E
    J Cell Biochem; 2010 Dec; 111(6):1445-52. PubMed ID: 20830741
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bone morphogenetic proteins, extracellular matrix, and mitogen-activated protein kinase signaling pathways are required for osteoblast-specific gene expression and differentiation in MC3T3-E1 cells.
    Xiao G; Gopalakrishnan R; Jiang D; Reith E; Benson MD; Franceschi RT
    J Bone Miner Res; 2002 Jan; 17(1):101-10. PubMed ID: 11771655
    [TBL] [Abstract][Full Text] [Related]  

  • 8. COMP-angiopoietin 1 increases proliferation, differentiation, and migration of stem-like cells through Tie-2-mediated activation of p38 MAPK and PI3K/Akt signal transduction pathways.
    Kook SH; Lim SS; Cho ES; Lee YH; Han SK; Lee KY; Kwon J; Hwang JW; Bae CH; Seo YK; Lee JC
    Biochem Biophys Res Commun; 2014 Dec; 455(3-4):371-7. PubMed ID: 25446117
    [TBL] [Abstract][Full Text] [Related]  

  • 9. COMP-angiopoietin-1 ameliorates renal fibrosis in a unilateral ureteral obstruction model.
    Kim W; Moon SO; Lee SY; Jang KY; Cho CH; Koh GY; Choi KS; Yoon KH; Sung MJ; Kim DH; Lee S; Kang KP; Park SK
    J Am Soc Nephrol; 2006 Sep; 17(9):2474-83. PubMed ID: 16885409
    [TBL] [Abstract][Full Text] [Related]  

  • 10. COMP-Ang1 promotes chondrogenic and osteogenic differentiation of multipotent mesenchymal stem cells through the Ang1/Tie2 signaling pathway.
    Kim S; Lee JC; Cho ES; Kwon J
    J Orthop Res; 2013 Dec; 31(12):1920-8. PubMed ID: 23893855
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potential of l-thyroxine to differentiate osteoblast-like cells via Angiopoietin1.
    Park SH; Lee J; Kang MA; Moon YJ; Wang SI; Kim KM; Park BH; Jang KY; Kim JR
    Biochem Biophys Res Commun; 2016 Sep; 478(3):1409-15. PubMed ID: 27569283
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Harmine promotes osteoblast differentiation through bone morphogenetic protein signaling.
    Yonezawa T; Lee JW; Hibino A; Asai M; Hojo H; Cha BY; Teruya T; Nagai K; Chung UI; Yagasaki K; Woo JT
    Biochem Biophys Res Commun; 2011 Jun; 409(2):260-5. PubMed ID: 21570953
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Simvastatin antagonizes tumor necrosis factor-alpha inhibition of bone morphogenetic proteins-2-induced osteoblast differentiation by regulating Smad signaling and Ras/Rho-mitogen-activated protein kinase pathway.
    Yamashita M; Otsuka F; Mukai T; Otani H; Inagaki K; Miyoshi T; Goto J; Yamamura M; Makino H
    J Endocrinol; 2008 Mar; 196(3):601-13. PubMed ID: 18310456
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined bone morphogenetic protein-2 and -7 gene transfer enhances osteoblastic differentiation and spine fusion in a rodent model.
    Zhu W; Rawlins BA; Boachie-Adjei O; Myers ER; Arimizu J; Choi E; Lieberman JR; Crystal RG; Hidaka C
    J Bone Miner Res; 2004 Dec; 19(12):2021-32. PubMed ID: 15537446
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of novel regulators associated with early-phase osteoblast differentiation.
    de Jong DS; Vaes BL; Dechering KJ; Feijen A; Hendriks JM; Wehrens R; Mummery CL; van Zoelen EJ; Olijve W; Steegenga WT
    J Bone Miner Res; 2004 Jun; 19(6):947-58. PubMed ID: 15125793
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Naringin-induced bone morphogenetic protein-2 expression via PI3K, Akt, c-Fos/c-Jun and AP-1 pathway in osteoblasts.
    Wu JB; Fong YC; Tsai HY; Chen YF; Tsuzuki M; Tang CH
    Eur J Pharmacol; 2008 Jul; 588(2-3):333-41. PubMed ID: 18495116
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epinephrine accelerates osteoblastic differentiation by enhancing bone morphogenetic protein signaling through a cAMP/protein kinase A signaling pathway.
    Uemura T; Ohta Y; Nakao Y; Manaka T; Nakamura H; Takaoka K
    Bone; 2010 Oct; 47(4):756-65. PubMed ID: 20637325
    [TBL] [Abstract][Full Text] [Related]  

  • 18. COMP-Ang1: a designed angiopoietin-1 variant with nonleaky angiogenic activity.
    Cho CH; Kammerer RA; Lee HJ; Steinmetz MO; Ryu YS; Lee SH; Yasunaga K; Kim KT; Kim I; Choi HH; Kim W; Kim SH; Park SK; Lee GM; Koh GY
    Proc Natl Acad Sci U S A; 2004 Apr; 101(15):5547-52. PubMed ID: 15060279
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Four and half lim protein 2 (FHL2) stimulates osteoblast differentiation.
    Lai CF; Bai S; Uthgenannt BA; Halstead LR; McLoughlin P; Schafer BW; Chu PH; Chen J; Otey CA; Cao X; Cheng SL
    J Bone Miner Res; 2006 Jan; 21(1):17-28. PubMed ID: 16355270
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Osteoactivin acts as downstream mediator of BMP-2 effects on osteoblast function.
    Abdelmagid SM; Barbe MF; Arango-Hisijara I; Owen TA; Popoff SN; Safadi FF
    J Cell Physiol; 2007 Jan; 210(1):26-37. PubMed ID: 17034042
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 56.